Colesterol y aterosclerosis. Consideraciones históricas y tratamiento
Author(s) -
Arturo Zárate,
Leticia ManuelApolinar,
Lourdes Basurto,
Elsa de la Chesnaye,
Iván Saldívar
Publication year - 2016
Publication title -
archivos de cardiología de méxico
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.149
H-Index - 17
eISSN - 1405-9940
pISSN - 1665-1731
DOI - 10.1016/j.acmx.2015.12.002
Subject(s) - coining (mint) , cholesterol , medicine , history , archaeology
Cholesterol is a precursor of steroid hormones and an essential component of the cell membrane, however, altered regulation of the synthesis, absorption and excretion of cholesterol predispose to cardiovascular diseases of atherosclerotic origin. Despite, the recognition of historical events for 200 years, starting with Michel Chevreul naming «cholesterol»; later on, Lobstein coining the term atherosclerosis and Marchand introducing it, Anichkov identifying cholesterol in atheromatous plaque, and Brown and Goldstein discovering LDL receptor; as well as the emerging of different drugs, such as fibrates, statins and cetrapibs this decade, promising to increase HDL and the most recent ezetimibe and anti-PCSK9 to inhibit the degradation of LDL receptor, however morbidity has not been reduced in cardiovascular disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom